Status
Conditions
Treatments
About
This will be a prospective observational multicentre study in real-life conditions of patients with complicated urinary infection of community presentation caused by Escherichia coli using intravenous fosfomycin, quinolones or beta-lactams.
It's a multicenter and multinational study and it will include 200 patients in the fosfomycin cohort and 200 patients in the control cohort (quinolones or beta-lactams).
Full description
The objectives are:
For objective 1, a study of prospective mated cohorts (fosfomycin cohort versus quinolones or beta-lactams cohort) will be performed, and for objectives 2 and 3 a prospective cohort study (fosfomycin cohort) will be conducted.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Fosfomycin cohort:
Control cohort (objective 1):
400 participants in 2 patient groups
Loading...
Central trial contact
Elisa Moreno Mellado; Belén Gutiérrez Gutiérrez
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal